N-ethyl-N-methyl-D-alanine | 1038919-38-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-ethyl-N-methyl-D-alanine
• 英文别名: (2R)-2-[ethyl(methyl)amino]propanoic acid
• CAS: 1038919-38-8
• 化学式: C₆H₁₃NO₂
• 分子量: 131.175
• InChiKey: VFAGOLZNWJDWBA-RXMQYKEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  44.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  N-carbobenzoyloxy-N-ethyl-D-alanine 、 聚合甲醛 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 、 水 为溶剂， 反应 20.0h， 以95%的产率得到N-ethyl-N-methyl-D-alanine
  参考文献：
  名称：

  Synthesis of N-alkyl-N-methyl amino acids. Scope and limitations of base-induced N-alkylation of Cbz-amino acids

  摘要：

  The reaction of N-benzyloxycarbonyl derivatives of aliphatic amino acids with NaH/alkyl iodides gave the corresponding N-Cbz-N-alkyl derivatives in good to high yields. The scope and limitations of this simple N-alkylation reaction were investigated as a convenient and flexible attempt to prepare unsymmetrically N,N-diprotected alpha-amino acids. The procedure is based on the N-alkylation of N-carbamoyl amino acids, a one-pot deprotection/protection sequence without extensive purification of the products. Protection of the carboxyl function is not required while the starting materials are inexpensive and commercially available. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2008.03.025

文献信息

• [EN] POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS<br/>[FR] ANTAGONISTES DE TLR7/8 POLYCYLIQUES ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES IMMUNES
  申请人：MERCK PATENT GMBH

  公开号：WO2017106607A1

  公开（公告）日：2017-06-22

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as toll-like receptor 7/8 (TLR7/8) antagonists. In Formula (I), Ring A is aryl or heteroaryl; Ring B is aryl or heteroary; and X is C(R4)2, O, NR4, S, S(R4), or S(R4)2.

  本发明涉及式(I)的化合物及其药学上可接受的组合物，作为Toll样受体7/8（TLR7/8）拮抗剂。在式(I)中，环A是芳基或杂芳基；环B是芳基或杂芳基；X是C(R4)2、O、NR4、S、S(R4)或S(R4)2。
• BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
  申请人：SINGH Jasbir

  公开号：US20120213758A1

  公开（公告）日：2012-08-23

  The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id: A particular embodiment is

  本发明涉及一类含有至少一个进一步环的双芳基化合物。这些化合物是PDE4抑制剂，可用于治疗和预防中风、心肌梗死和心血管炎症性疾病和紊乱。这些化合物的一般式为Ia、Ib、Ic或Id：其中一种特定的实施例为：
• TLR7/8 antagonists and uses thereof
  申请人：Merck Patent GmbH

  公开号：US10399957B2

  公开（公告）日：2019-09-03

  The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.

  本发明涉及可用作 TLR7/8 拮抗剂的式 I 化合物及其药学上可接受的组合物。
• POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS
  申请人：Merck Patent GmbH

  公开号：EP3390389A1

  公开（公告）日：2018-10-24
• EP3889145A1
  申请人：——

  公开号：EP3889145A1

  公开（公告）日：2021-10-06